A novel tumor‐related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma
- 6 February 2007
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 1 (2) , 192-199
Abstract
Proteome analysis of bladder cancer with narrow‐range pH 2‐DE has identified a novel protein on chromosome 7 encoded by ORF 24 (C7orf24) as one of the highly expressed proteins in cancer cells. C7orf24 is currently registered in the protein database as a hypothetical protein with unknown function. The homologs of C7orf24 in other animals have also been registered as putative protein genes. Western blot analysis using a mAb against C7orf24 confirmed its higher expression in bladder cancer compared with normal tissue. Several other cancer cell lines were also found to express C7orf24. However, the introduction of C7orf24 into Rat‐1 or NIH3T3 cells did not cause malignant transformation. A stable transfectant of NIH3T3 cells with recombinant retrovirus vector was produced for a growth rate assay, and a higher growth rate was observed in C7orf24‐expressing cells compared with the controls. Six kinds of small interfering RNAs (siRNAs) were then produced, and C7orf24‐siRNA#5 showed a strong knockdown effect on protein expression and significant antiproliferative effects on cancer cell lines were demonstrated by the MTT assay. Therefore, C7orf24 may have an important role in cancer cell proliferation, and may be an appropriate therapeutic target molecule against cancer.Keywords
This publication has 10 references indexed in Scilit:
- Proteomics and disease: opportunities and challengesMedical Journal of Australia, 2005
- Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancerJournal of Clinical Investigation, 2005
- Proteomic analysis for the early detection and rational treatment of cancer—realistic hope?Annals of Oncology, 2005
- Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of CancerClinical Cancer Research, 2004
- Identification by Proteomic Analysis of Calreticulin as a Marker for Bladder Cancer and Evaluation of the Diagnostic Accuracy of Its Detection in UrineClinical Chemistry, 2004
- Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformationProceedings of the National Academy of Sciences, 2003
- Structural Diversity of Cancer-related and Non-Cancer-related Prostate-specific AntigenClinical Chemistry, 2002
- High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell CarcinomaJapanese Journal of Cancer Research, 2002
- Proteomics: new perspectives, new biomedical opportunitiesThe Lancet, 2000
- SINGLE‐STEP PURIFICATION OF PROSTATIC ACID PHOSPHATASE: IMMUNOAFFINITY CHROMATOGRAPHY WITH A MONOCLONAL ANTIBODYInternational Journal of Urology, 1995